2017
DOI: 10.1097/qai.0000000000001454
|View full text |Cite
|
Sign up to set email alerts
|

Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
24
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(30 citation statements)
references
References 25 publications
5
24
1
Order By: Relevance
“…In the present study, statin prescribing rates were significantly lower for PLWH compared to uninfected patients before and after adjusting for baseline characteristics. The primary outcome results coincide with prior study literature describing the existence of a statin prescribing gap in the HIV-infected population despite PLWH being at increased risk for CVD [15,[18][19][20]22,24,25]. Smoking, primary inclusion criteria, older age, HIV-infected status, and HCV-infected status were independent predictors of being prescribed a statin.…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…In the present study, statin prescribing rates were significantly lower for PLWH compared to uninfected patients before and after adjusting for baseline characteristics. The primary outcome results coincide with prior study literature describing the existence of a statin prescribing gap in the HIV-infected population despite PLWH being at increased risk for CVD [15,[18][19][20]22,24,25]. Smoking, primary inclusion criteria, older age, HIV-infected status, and HCV-infected status were independent predictors of being prescribed a statin.…”
Section: Discussionsupporting
confidence: 80%
“…This suggests that PLWH at risk for ASCVD are not receiving primary prevention with a statin; however, they are receiving secondary prevention at rates similar to those in uninfected patients. Previous studies have assessed statin prescribing rates in PLWH [15,[18][19][20]22,24,25]. Of the studies that included patients based on the 2013 ACC/AHA lipid guidelines, prescribing rates ranged from 36% to 56% [19,[22][23][24].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These prescribing outcomes in team‐based care are much higher than previously described. Three studies observed a rate of 49% to 56% of HIV‐infected patients prescribed statin therapy when indicated and 56% prescribed appropriate statin intensity . Frieberg and colleagues reported that 36% of PLWH with CHD or CHD equivalents did not receive statin therapy; this differed from the current study in which all PLWH with a history of ASCVD or T2DM received statin therapy .…”
Section: Discussioncontrasting
confidence: 72%
“…The difference in statin prescribing between HIV‐infected and uninfected patients has been reported to be as high as 22%, with gross underutilization observed in PLWH with known coronary heart disease (CHD) or risk equivalents . When statin prescribing was assessed in PLWH, less than half of patients in whom a statin was indicated were prescribed these medications (based on the 2013 American College of Cardiology/American Heart Association [ACC/AHA] treatment guidelines) . Given the increase in CVD risk in PLWH, this paper presents the outcomes of statin utilization in PLWH who received team‐based care compared with those who received standard care.…”
Section: Introductionmentioning
confidence: 99%